La Vignera Sandro, Condorelli Rosita A, Mongioi Laura M, Calogero Aldo E
Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Int J Endocrinol. 2017;2017:3848545. doi: 10.1155/2017/3848545. Epub 2017 Mar 30.
Aim of this study was to evaluate the effects of pharmacological treatment with Tadalafil 5 mg daily on symptoms and quality of sperm parameters in selected patients with amicrobic MAGI (male accessory gland inflammation). 120 patients with amicrobic MAGI (mean age 27.0 ± 6.0 years) with mild-moderate ED (erectile dysfunction) according to IIEF-5 (International Index of Erectile Function 5 Items) scores underwent pharmacological treatment with Tadalafil 5 mg daily for six months. Before and after treatment these patients were evaluated through IIEF-5, semen analysis (according to WHO Criteria, 2010), SI-MAGI (Structured Interview about Male Accessory Gland Inflammation), and ultrasound evaluation. Patients with PVE (prostate-vesciculo-epididymitis) showed a significant increase in the percentage of spermatozoa with total (16.0 ± 8.0 versus 30.0 ± 6.0%) and progressive motility (8.00 ± 10.0 versus 25.0 ± 6.00%). It was a significant reduction of the number of patients with complicated ultrasound forms (30.0 versus 52.0) and a significant increase of the number of patients with uncomplicated ultrasound form (90.0 versus 68.0). Finally, there was a significant reduction in the percentage of patients with alterations of sexual function different from DE, such as premature ejaculation (4.00 versus 8.00%), painful ejaculation (4.00 versus 10.0%), delayed ejaculation (12.50 versus 8.00%), and decreased libido (10.0 versus 25.0%).
本研究的目的是评估每日服用5毫克他达拉非进行药物治疗对部分无微生物感染的男性附属腺炎(MAGI)患者的症状及精子参数质量的影响。120例根据国际勃起功能指数5项(IIEF-5)评分患有轻度至中度勃起功能障碍(ED)的无微生物感染的MAGI患者(平均年龄27.0±6.0岁)接受了为期6个月的每日5毫克他达拉非药物治疗。在治疗前后,通过IIEF-5、精液分析(根据2010年世界卫生组织标准)、男性附属腺炎结构化访谈(SI-MAGI)和超声评估对这些患者进行了评估。患有前列腺-精囊-附睾炎(PVE)的患者精子总数(16.0±8.0%对30.0±6.0%)和进行性运动能力(8.00±10.0对25.0±6.00%)的百分比显著增加。超声复杂形式的患者数量显著减少(30.0对52.0),超声简单形式的患者数量显著增加(90.0对68.0)。最后,除勃起功能障碍(DE)外的性功能改变患者百分比显著降低,如早泄(4.00%对8.00%)、射精疼痛(4.00%对10.0%)、射精延迟(12.50%对8.00%)和性欲减退(10.0%对25.0%)。